Clinical validation of prognostic biomarkers of chemotherapy response in liquid biopsies

Zhe Li

IGF/IGF1R signaling in hematopoiesis and leukemogenesis

Leukaemia

Xuefang Cao

Targeting Granzyme B to Separate GVH from GVL Responses

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Seth J Corey

Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML

Leukaemia

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Michele S Redell

Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML

Leukaemia

Hematology and hematologic malignancies

Clark W Distelhorst

Targeting PKM2-InsP3R interaction to treat AML

Leukaemia

Hematology and hematologic malignancies

Alex Kentsis

Aberrant activation of HGF/MET signaling as a therapeutic target in AML

Leukaemia

Investigator from Georg Speyer Haus

Functional and Molecular Analyses of the Interplay between Hematopoietic and Mesenchymal Niche Cells in Human Myelodysplastic Syndromes

Leukaemia

Margaret A Goodell

A Mouse Model of DNMT3A-Associated Hematologic Malignancy

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Crystal Mackall

Clinical Trials of Immunotherapies for Childhood Cancer

Sarcoma Trachea, bronchus and lung Melanoma of skin Leukaemia

Pediatric oncology or childhood cancer